Three chemotherapy studies of tuberculous meningitis in children

Ramachandran, Padma; Duraipandian, M.; Nagarajan, M.; Prabhakar, R.; Ramakrishnan, C.V. and Tripathy, S.P. (1986) Three chemotherapy studies of tuberculous meningitis in children. Indian Journal of Tuberculosis, 33 (2). pp. 56-65.

Full text available as:

PDF - Requires Adobe Acrobat Reader or other PDF viewer.
205 Kb

Abstract

Chemotherapy studies were undertaken in 180 patients with tuberculous meningitis. They were treated for 12 months with 3 regimens: the first consisted of streptomycin, isoniazid and rifampicin daily for the first 2 months, followed by ethambutol plus isoniazid for 10 months; in the second, pyrazinamide was added for the first 2 months, and in the third, rifampicin was reduced to twice weekly in the first 2 months. In the first regimen alone, streptomycin was also given twice weekly from the third to the sixth month. Steroids were prescribed for all the patients in the initial weeks of treatment. Approximately 50% of the patients were aged less than 3 years. On admission, 13%of the patients were classified as stage 1,77% as stage Hand 9% as stage III. Cerebrospinal fluid (CSF) culture results were available for all the 180 patients and M. tuberculosis was isolated in 59 (33%). CSF smear results for acid fast bacilli were available only for the 103 patients admitted to the second and the third studies, and of these, in 60 (58%) the CSF was positive either by smear or culture. The response to therapy was similar in the 3 studies. Despite administration of rifampicin for 2 months, the mortality was high. In all, 27% of the patients died of tuberculous meningitis, 39% had neurological sequel and 34% recovered completely. There was a strong association between i l u stage on admission and the mortality rate, the deaths being highest in stage III. In the first study; when isoniazid was prescribed daily in a dosage of 20 mg/kg, 39 % of the patients developed jaundice however, when the dosage was reduced to 12 mg/kg, the incidence was only 16%. In the third study. where rifampicin was administered twice a week, the incidence of jaundice was low (5%).

EPrint Type:Article
Uncontrolled Keywords:Tuberculous Meningitis, Chemotherapy, Streptomycin, Isoniazid, Rifampicin, Ethambutol, Pyrazinamide, Drug Regimens, Cerebrospinal Fluid Culture, Culture, Death, Mortality, Smear, Patients
Subjects:Environment and Public Health > Public Health > Epidemiologic Measurements > Demography > Vital Statistics > Mortality
Bacterial Infections and Mycoses > Bacterial Infections > Gram-Positive Bacterial Infections > Actinomycetales Infections > Mycobacterium Infections > Tuberculosis
Therapeutics > Drug Therapy
Diagnosis > Prognosis
Organic Chemicals > Hydrazines > Isoniazid
Nutritional and Metabolic Diseases > Metabolic Diseases > Hyperbilirubinemia
Bacterial Infections and Mycoses > Central Nervous System Infections > Central Nervous System Bacterial Infections
Heterocyclic Compounds > Heterocyclic Compounds with 4 or More Rings > Rifamycins
Fluids and Secretions > Body Fluids
Investigative Techniques > Clinical Laboratory Techniques > Culture Techniques
Skin and Connective Tissue Diseases > Skin Diseases > Skin Manifestations
Investigative Techniques > Epidemiologic Methods > Data Collection > Vital Statistics > Mortality
Persons > Age Groups > Child
Bacterial Infections and Mycoses > Bacterial Infections > Central Nervous System Bacterial Infections
Organic Chemicals > Amines > Polyamines
Carbohydrates and Hypoglycemic Agents > Carbohydrates > Glycosides > Aminoglycosides > Streptomycin
Pathological Conditions, Signs and Symptoms > Pathologic Processes > Hyperbilirubinemia
Persons > Age Groups > Infant
Heterocyclic Compounds > Heterocyclic Compounds, 1-Ring > Pyrazines
Pathological Conditions, Signs and Symptoms > Signs and Symptoms > Skin Manifestations
-Journal Repositories > Indian Journal of Tuberculosis
ID Code:3001
Deposited By:Mrs Naina Pandita
Deposited On:22 August 2008

Archive Staff Only: edit this record